XRCC1-77T>C polymorphism and cancer risk: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 111-115

  Wang, Yong Gang ^a   Zheng, Tian Ying ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cancer; Genetic polymorphism; Meta analysis; XRCC1

Indexed keywords

DNA BINDING PROTEIN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; XRCC1 PROTEIN;

ARTICLE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; NEOPLASM; PROGNOSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS;

EID: 84864881806     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.111     Document Type: Article

References (27)

1. Almeida KH, Sobol RW (2007). A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair, 6, 695-711.
2. Basso D, Navaglia F, Fogar P, et al (2007). DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis. Clin Chimica Acta, 381, 50-5.
3. Betti M, Ferrante D, Padoan M, et al (2011). XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study. Mutation Res, 708, 11-20.
4. Brem R, Cox DG, Chapot B, et al (2006). The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis, 27, 2469-74.
5. Campalans A, Marsin S, Nakabeppu Y, et al (2005). XRCC1 interactions with multiple DNA glycosylases: a model for its recruitment to base excision repair. DNA Repair, 4, 826-35.
6. Cochran WG (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29.
7. Corso G, Marrelli D, Pedrazzani C, et al (2009). Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1). J Gastrointest Surg, 13, 2233-8.
8. Dai L, Wang K, Zhang J, et al (2009). XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies. Int J Cancer, 125, 1102-9.
9. Das A, Wiederhold L, Leppard JB, et al (2006). NEIL2-initiated, APE-independent repair of oxidized bases in DNA: Evidence for a repair complex in human cells. DNA Repair, 5, 1439-48.
10. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Controlled Clin Trials, 7, 177-88.
11. De Ruyck K, Szaumkessel M, De Rudder I, et al (2007). Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutation Res, 631, 101-10.
12. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
13. Ginsberg G, Angle K, Guyton K, et al (2011). Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment. Mutation Res, 727, 1-15.
14. Hao B, Miao X, Li Y, et al (2006). A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene, 25, 3613-20.
15. Hao B, Wang H, Zhou K, et al (2004). Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res, 64, 4378-84.
16. Hsieh WC, Cheng YW, Lin CJ, et al (2009). Prognostic significance of X-ray cross-complementing group 1 T-77C polymorphism in resected non-small cell lung cancer. Jpn J Clinic Oncol, 39, 81-5.
17. Huang Y, Li L, Yu L (2009). XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis, 24, 331-9.
18. Hu Z, Ma H, Lu D, et al (2005). A promoter polymorphism (-77T>C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking. Pharmacogenet Genomics, 15, 457-63.
19. Lao T, Gu W, Huang Q (2008). A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk. Mutagenesis, 23, 523-32.
20. Li M, Yin Z, Guan P, et al (2008). XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers. Lung Cancer, 62, 145-51.
21. Liu L, Yuan P, Wu C, et al (2011). A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res Treat, 125, 479-87.
22. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
23. Sak SC, Barrett JH, Paul AB, et al (2007). DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genetics, 8, 13.
24. Sterpone S, Mastellone V, Padua L, et al (2010). Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol, 136, 631-6.
25. Tudek B (2007). Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med, 28, 258-75.
26. Vidal AE, Boiteux S, Hickson ID, et al (2001). XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J, 20, 6530-9.
27. Wang M, Qin C, Zhu J, et al (2010). Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol, 29, 303-11